Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2017
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 04 May 2017 Status changed from not yet recruiting to recruiting.
- 26 Feb 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 26 Feb 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018.